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Abstract 
Purpose: To study and compare the analgesic, anti-inflammatory and immuno-modulatory effects of 
dezocine-propofol, and fentanyl-propofol combinations in colonoscopy. 
Methods: One hundred and thirty-four patients who received painless colonoscopy in Eastern Medical 
District of Linyi People's Hospital, Linyi City, Shandong Province, China, from June 2013 to December 
2016 were randomly divided into two groups. Patients in the observation group (aged 42 - 65 years) 
received dezocine-propofol combination as anesthesia, while those in the control group (aged 41 - 67 
years) were anesthetized with fentanyl-propofol. Serum levels of pain and inflammatory mediators, as 
well as contents of immune response molecules were determined prior to, during and after colonoscopy 
using either enzyme-linked immunosorbent assay (ELISA) or electro-chemiluminescence kits. 
Results: There were no statistically significant differences in the serum levels of 5-hydroxytryptophan 
(5-HTP), 5-hydroxy indole acetic acid (5-HIAA), substance P (SP), prostaglandin E2 (PGE2), C-reactive 
protein (CRP), heat shock protein 70 (HSP70), Interleukin-1 β(IL-1β), adrenocorticotropic hormone 
(ACTH), Cortisol (Cor), Inositol (Ins), c-peptide (C-P), immunoglobulin G (IgG) and immunoglobulin A 
(IgA), complement 3 (C3) and complement 4 (C4) before and during colonoscopy between the two 
groups of patients. However, after the examination, serum levels of 5-HTP, 5-HIAA, SP, PGE2, CRP, 
HSP70, IL-1 beta, ACTH, Cor, Ins and C-P in the observation group were significantly lower than those 
in control group (p < 0.05), while IgG, IgA, C3 and C4 contents were significantly higher than those of 
the control group (p < 0.05).  
Conclusion: These results suggest that the analgesic effect of dezocine-propofol combination after 
colonoscopy examination is superior to that of fentanyl-propofol combination, due to its effectiveness in 
inhibiting inflammatory reactions and improving immune response. 
 
Keywords: Colonoscopy, Dezocine, Propofol Fentanyl, Pain mediators, Analgesic, Inflammatory 
reaction, Immune response 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Fiber colonoscopy is an important auxiliary 
examination procedure for diagnosing colorectal 
diseases in clinics. However, during inspection, 
the patient may feel pain and discomfort when 
colonoscopy goes across the hepatic and splenic 
flexure. These feelings are experienced in severe 
situations, leading to various degrees of 
abdominal discomfort and pain after the 
inspection. Painless colonoscopy is a newly 
developed technique that relieves the pain and 
discomfort associated with colonoscopy 
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examination through the use of a combination of 
a sedative and an analgesic [1,2]. Dezocine-
propofol and fentanyl-propofol are two kinds of 
frequently used anesthetic combinations for 
achieving painless colonoscopy. Dezocine and 
fentanyl exert analgesic effects, the former 
through activation of κ receptor in the cerebral 
cortex, and the latter through excitation of μ and 
δ receptors in the central nervous system (CNS) 
[3-5]. The present study was carried out to 
compare the anti-inflammatory and immuno-
modulatory effects of these two types of 







One hundred and thirty-four patients who 
received painless colonoscopy in our hospital 
(Eastern Medical District of Linyi People's 
Hospital, Linyi City, Shandong Province, China) 
from June 2013 to December 2016 participated 
in this study. This research was approved by 
Ethical Committee of The People's Hospital of 
Pingyi County (approval no. LY2013053) and 
was carried out according to the guidelines of 
Declaration of Helsinki promulgated in 1964, as 
amended in 1996 [6]. All the patients presented 
with colonoscopy indications, voluntarily 
accepted receiving painless colonoscopy, and 
signed informed consent. They were randomly 
divided into observation and control groups, each 
having 67 patients. Patients in the observation 
group (42 males and 25 females, aged 42 - 65 
years) received dezocine-propofol combination 
anesthesia, while those in the control group (40 
males and 27 females, aged 44- 63 years) were 
anesthetized with a combination of fentanyl and 
propofol. There were no significant differences in 
general characteristics between patients in the 




The upper extremity venous access was 
conventionally employed with ECG monitor and 
nasal catheter for oxygen inhalation. Anesthesia 
was induced and maintained in patients in the 
observation group by intravenous injection of 
5mg dezocine, 1 – 2 mg/kg propofol, as well as 
intra-operative micro-pump injection of 2 – 4 
mg/kg/h propofol. On the other hand, patients in 
the control group were anesthetized by 
intravenous injection of 0.05 mg fentanyl, 1 – 2 
mg/kg propofol and intra-operative micro-pump 
injection of 2 – 4 mg/kg/h propofol. At the onset 
of anesthesia, the same group of doctors 
conducted colonoscopy on both groups of 
patients, sent the patients to the recovery room 
after the examination, and stayed there with 
them until they regained consciousness and 
stable vital signs were stable. 
 
Determination of biochemical indices 
 
Peripheral blood samples (3 - ml) were collected 
from the two groups of patients before, during 
and after colonoscopy, and allowed to clot. 
Serum samples were obtained by centrifugation 
and used for assay of 5-HTP and5-HIAA (by RIA 
kits); SP, PGE2, CRP, HSP70, ACTH, Cor, IL-1 
beta, C-P, IgG IgA, C3 and C4 (by ELISA kits), 




SPSS 20.0 software was used to analyze the 
data from serum assays. The data are expressed 
as mean ± standard deviation (mean ± SD); data 
from the two groups were analyzed by t–test. P ˂ 





Serum levels of pain indicators 
 
No statistically significant differences were 
observed in serum levels of 5-HTP, 5-HIAA, SP 
and PGE2 between the two groups prior to, and 
during colonoscopy (p > 0.05). However, after 
colonoscopy, serum levels of 5-HTP, 5-HIAA, SP 
and PGE2 in the observation group were 
significantly lower than corresponding values in 
the control group (p < 0.05). These results are 
shown in Table 1. 
 
Table 1: Serum levels of pain indicators before and after colonoscopy examination (mean ± SD) 
 
Group Time point 5-HTP (µmol/L) 5-HIAA (µmol/L) SP (mg/L) PGE2 (ng/L) 
Observation 
Before 42.51 ± 6.62 57.29 ± 8.21 2.15 ± 0.35 68.49 ± 9.31 
During 53.59 ± 7.81 63.24 ± 9.18 2.95 ± 0.42 74.28 ± 8.93 
After 62.19 ± 8.72* 74.18 ± 9.63* 3.47 ± 0.61* 89.21 ± 9.74* 
Control 
Before 43.03 ± 6.92 58.02 ± 7.98 2.23 ± 0.38 69.11 ± 9.83 
During 53.21 ± 7.25 64.18 ± 8.69 3.01 ± 0.49 74.19 ± 9.58 
After 79.35 ± 9.68* 93.82 ± 11.02* 6.58 ± 0.93* 141.58 ± 18.76* 
*P ˂ 0.05 when compared to the control group at the same time point 
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Serum levels of inflammatory cytokines 
 
The results obtained showed that there were no 
statistically significant differences in serum levels 
of CRP, HSP70 andIL-1β between the two 
groups of patients before and during 
colonoscopy. Interestingly, after colonoscopy, 
serum levels of CRP, HSP70 and IL-1β in the 
observation group were significantly lower than 
those in the control group (Table 2, p < 0.05). 
 
Serum contents of inflammation-related 
endocrine hormones 
 
Prior to, and during colonoscopy, there no 
significant differences in serum ACTH, Cor, Ins 
and C-P levels between patients in the 
observation group and patients in the control 
group (p > 0.05). However, after colonoscopy, 
serum levels of these parameters were 
significantly lower in the observation group than 
those in the control group (p < 0.05). These 
results are presented in Table 3. 
 
Serum levels of humoral immune response 
molecules 
 
There were no statistically significant differences 
in serum levels of the humoral immune response 
molecules IgG, IgA, C3 and C4 between the two 
groups of patients before and during 
colonoscopy (p > 0.05). However, after 
colonoscopy, results revealed that serum levels 
of IgG, IgA, C3 andC4 in the observation group 
were significantly higher than those in the control 




Dezocine-propofol, and fentanyl-propofol are two 
anesthetic combinations frequently used in 
painless colonoscopy. Propofol has a sedative 
effect, while both dezocine and fentanyl exert 
analgesic effects. Dezocine activates κ receptor 
in cerebral cortex, leading to slow onset and long 
duration of analgesia [3,7,8], 
Table 2: Comparison of serum levels of inflammatory cytokines in the two groups of patients before 
and after colonoscopy examination (mean ± SD) 
 
Group Time point CRP (mg/L) HSP70 (ng/mL) IL-1β (ng/L) 
Observation 
Before 2.95 ± 0.52 0.56 ± 0.08 5.68 ± 0.93 
During 3.41 ± 0.59 0.70 ± 0.09 6.61 ± 0.84 
After 4.29 ± 0.61* 0.81 ± 0.11* 7.93 ± 0.97* 
Control 
Before 3.02 ± 0.47 0.52 ± 0.06 5.73 ± 0.88 
During 3.29 ± 0.61 0.72 ± 0.10 6.82 ± 0.92 
After 6.58 ± 0.94* 1.21 ± 0.18* 11.29 ± 1.86* 
P ˂ 0.05 when compared to the control group at the same time point 
 
Table 3: Serum levels of inflammation-related endocrine hormones before and after colonoscopy 
examination (mean ± SD) 
 
Group Time point ACTH (pmol/L) Cor (nmol/L) Ins (mIU/L) C-P (ng/mL) 
Observation 
Before 15.22 ± 2.35 265.21 ± 36.75 6.97 ± 0.95 0.52 ± 0.08 
During 18.95 ± 2.95 294.35 ± 42.19 7.71 ± 1.02 0.70 ± 0.11 
After 22.14 ± 4.82* 362.52 ± 46.79* 9.32 ± 1.16* 0.83 ± 0.12* 
Control 
Before 15.51 ± 1.95 266.31 ± 32.52 7.04 ± 0.85 0.55 ± 0.05 
During 19.25 ± 2.86 298.42 ± 42.86 7.93 ± 1.08 0.78 ± 0.10 
After 34.25 ± 6.85* 478.49 ± 65.28* 14.28 ± 1.86* 1.21 ± 0.18* 
      *P ˂ 0.05 when compared to the control group at the same time point 
 
Table 4: Serum levels of humoral immune response molecules before and after colonoscopy 
examination (mean ± SD) 
 
Group Time point IgG (mg/L) IgA (mg/L) C3 (g/L) C4 (g/L) 
Observation 
Before 12.83 ± 1.62 26.48 ± 3.52 0.95 ± 0.12 0.64 ± 0.09 
During 12.17 ± 1.56 25.03 ± 3.26 0.91 ± 0.13 0.61 ± 0.10 
After 11.32 ± 1.95* 23.47 ± 3.15* 0.85 ± 0.09* 0.55 ± 0.08* 
Control 
Before 12.91 ± 1.88 26.91 ± 3.66 0.97 ± 0.14 0.65 ± 0.11 
During 12.08 ± 1.86 24.58 ± 3.16 0.90 ± 0.11 0.62 ± 0.08 
After 9.49 ± 1.28* 20.12 ± 3.09* 0.72 ± 0.09* 0.42 ± 0.07* 
*P ˂ 0.05 when compared to the control group at the same time point 
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while fentanyl brings about fast onset but short-
lived analgesia through activation of the μ and δ 
receptors in the central nervous system (CNS). 
Thus the use of fentanyl after colonoscopy 
examination is not ideal. Pain relief after 
inspection is an outstanding feature of painless 
colonoscopy [9].  
 
Pain leads to secretion and release of some 
pain-associated neurotransmitters. Indole 
neurotransmitters such as 5-HTP and 5-HIAA are 
involved in amplification of pain sensation and 
pain signal transduction [10]. Substance P (SP) 
is a nerve fiber neuropeptide involved in the 
transmission of pain signals from the peripheral 
to the CNS [11]. PGE2, an inflammatory pain 
transmitter which functions at nerve endings, 
increases the sensitivity of nerve endings to pain 
stimulation, and also decreases pain threshold 
[12]. In order to compare the analgesic effects of 
the two anesthesia combinations, the present 
study analyzed the serum levels of pain 
mediators associated with their use before, 
during and after colonoscopy. The results 
showed that before and during colonoscopy, 
there were no statistically significant differences 
in 5-HTP, 5-HIAA, SP andPGE2between patients 
in the observation group and those in the control 
group. However, after colonoscopy inspection, 
serum contents of these pain mediators were 
significantly lower in the observation group when 
compared to the control group. This implies that 
the analgesic effect of dezocine-propofol 
combination after colonoscopy was superior to 
that of fentanyl-propofol combination.  
 
Pain is associated with the activation of 
inflammatory reactions which are mediated by 
cytokines. Activation of inflammatory response 
results in release CRP, HSP70, IL-1β and other 
cytokines into the blood circulation. CRP is a 
liver-synthesized reactive protein released in the 
acute phase of inflammation. A variety of pro-
inflammatory factors stimulate the synthesis and 
secretion of CRP. The extent of release of the 
latter is directly proportional to the degree of 
inflammation [13].  
 
HSP70 is a member of the heat shock protein 
family which regulates the stability of intracellular 
peptides [14]. Its secretion is increased in 
response to inflammatory reactions [14]; IL-1β is 
an important pro-inflammatory mediator derived 
from mononuclear macrophages and 
lymphocytes. It mediates the amplification 
cascade of inflammatory reactions [15,16]. The 
results obtained in this study indicate that before 
and during colonoscopy inspection, there were 
no significant differences in the serum contents 
of CRP, HSP70 and IL-1βbetween the two 
groups. Interestingly, after colonoscopy, serum 
CRP, HSP70 and IL-1β levels in the observation 
group were significantly lower than 
corresponding values in the control group. This 
means that the extent of inflammation-associated 
cytokine release into the blood after colonoscopy 
was lower in the observation group than in the 
control group. This finding lends further credence 
to the superiority of the analgesic effect of 
dezocine-propofol combination over that of 
fentanyl-propofol combination. 
 
The release of inflammatory cytokines is a direct 
manifestation of activation of inflammation 
reaction. Inflammatory reactions provoke 
abnormal hormone secretion and inhibition of 
immune response [17]. The HPA axis is an axis 
through which the endocrine glands respond to 
stress response. Studies have shown that 
stressors activate the HPA axis and increase the 
secretion of ACTH which acts on adrenal cortex 
and increases the secretion of Cor [18,19]. It has 
been reported that Cor can suppress the immune 
response to a certain extent, and it also 
influences the synthesis and secretion of IgG, 
IgA and C3 [20,21].  
 
In the present study, there were no significant 
differences in serum levels of ACTH, Cor, Ins 
and C-P between patients in the observation 
group and those in the control group, before and 
during colonoscopy. However, after colonoscopy 
examination, results showed that these 
parameters were significantly lower in the serum 
samples from the observation group when 
compared to the control group. This indicates 
that, following colonoscopy, the dezocine-
propofol combination elicited release of less 
inflammation-associated hormones than the 
fentanyl-propofol combination, which implies less 
inhibition of humoral immunity after colonoscopy. 
This view is supported by the higher levels of 
IgG, IgA, C3 and C4 levels in the observation 
group after the procedure. It also provides 
additional evidence for the superior analgesic 
effect of dezocine-propofol formulation over that 




The results of serological analysis obtained in the 
present investigation suggest that after 
colonoscopy examination, the analgesic and anti-
inflammatory effects of dezocine-propofol 
formula were superior to those of fentanyl-
propofol combination. Thus, dezocine-propofol 
combination suppresses the secretion of pain 
mediators, relieve pain and improve immune 
response more effectively than fentanyl-propofol 
combination. 
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